고분자 바이오 분석 기술 시장 규모, 점유율, 동향 분석 보고서 : 제품 및 서비스별, 용도별, 지역별, 부문 예측(2025-2030년)

Large Molecule Bioanalytical Technologies Market Size, Share & Trends Analysis Report By Products & Services, By Application (Biologics, Oligonucleotide Derived Drugs & Molecules), By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,575,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 10,017,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,899,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

한글목차

고분자 바이오 분석 기술 시장의 성장과 동향

Grand View Research, Inc.의 최신 보고서에 따르면 세계의 고분자 바이오 분석 기술 시장 규모는 2025-2030년에 걸쳐 10.2%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상되며, 2030년까지 167억 6,000만 달러에 달할 것으로 추정됩니다.

바이오 분석 시험 서비스에 대한 수요는 지난 몇 년 동안 크게 증가하고 있으며 시장 성장에 긍정적인 영향을 미쳤습니다.

이는 주로 바이오 의약품 산업에서 R&D 활동의 확대가 이 부문에 대한 주목할만한 투자로 이어지고 있기 때문입니다. 또한 현재 진행 중인 COVID-19의 대유행에 의해 주요 이해관계자의 제조 및 연구개발 능력이 확대되어 생물분석검사 서비스 수요 증가로 이어지고 있습니다. 백신 및 세포 유전자 치료의 개발에 첨단 기술의 사용은 이 부문의 현저한 성장으로 이어졌습니다.

장비의 진보는 수탁 제조자에게 유리한 기회를 창출하고 있습니다. 최근 몇 년 동안 바이오 의약품 제조업체는 바이오 제조 활동의 적어도 일부를 아웃소싱하고 있습니다. 분석 검사는 분석을 수행하기 위해 고도로 전문화된 인력과 장비가 필요하기 때문에 가장 아웃소싱된 활동 중 하나입니다. 이러한 요인은 시장 성장 형성에 중요한 역할을 할 것으로 예측됩니다.

고분자 바이오 분석 기술 시장 보고서 하이라이트

• 2024년에는 제품 부문이 71.5%의 최대 수익 점유율로 시장을 독점하여 생물 제제 분석에 사용되는 첨단 도구 및 장비에 대한 수요가 높아졌습니다.
• 용도별로는 단일클론항체, 유전자 치료, 바이오시밀러를 포함한 생물 제제의 급성장에 의해 생물 제제 부문이 2024년에 최대의 수익 점유율을 확보했습니다.
• 세포 및 유전자 치료 용도 부문은 예측 기간 중에 가장 빠른 CAGR로 성장할 것으로 예상되고 있습니다.
• 2024년에는 북미가 세계 시장에서 34.2%의 최대의 매출 점유율을 차지해, 재생 의료의 동향의 고조와, 암이나 희귀질환에 대한 관심의 고조가 그 원동력이 되고 있습니다.
• 아시아태평양은 예측기간 중 CAGR이 11.7%로 가장 급성장하고 있는 지역이 될 것으로 예측되고 있습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 고분자 바이오 분석 기술 시장의 변수, 동향, 범위

• 시장 계통의 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 비즈니스 환경 분석
  • 산업 분석 - Porter's Five Forces 분석
  • PESTLE 분석

제4장 고분자 바이오 분석 기술 시장 : 제품 및 서비스 비즈니스 분석

• 제품 및 서비스 시장 점유율, 2024년과 2030년
• 제품 및 서비스 부문 대시보드
• 시장 규모, 예측, 동향 분석(제품 및 서비스별, 2018-2030년)
• 제품
• 서비스

제5장 고분자 바이오 분석 기술 시장 : 용도 비즈니스 분석

• 용도 시장 점유율, 2024년과 2030년
• 용도 부문 대시보드
• 시장 규모, 예측, 동향 분석(용도별, 2018-2030년)
• 생물제제
• 올리고뉴클레오티드 유래의 의약품과 분자
• 바이러스 벡터
• 세포 및 유전자 치료
• 나노입자와 폴리머

제6장 고분자 바이오 분석 기술 시장 :지역별, 추정 및 동향 분석

• 지역별 시장 점유율 분석, 2024년과 2030년
• 지역별 시장 대시보드
• 시장 규모, 예측 동향 분석, 2018-2030년
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 태국
  • 한국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제7장 경쟁 구도

• 참가자 개요
• 기업의 시장 포지셔닝 분석
• 기업 분류
• 전략 매핑
• 기업 프로파일/상장 기업
  • Intertek Group plc
  • Solvias
  • Bio-Techne
  • Waters Corporation
  • Cytiva
  • Verder Scientific GmbH & Co. KG
  • Halo Labs
  • Charles River Laboratories
  • Avomeen
  • Merck KGaA
  • Cergentis BV
  • Labcorp
  • SCIEX
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories, Inc.

SHW

영문 목차

영문목차

Large Molecule Bioanalytical Technologies Market Growth & Trends:

The global large molecule bioanalytical technologies market size is estimated to reach USD 16.76 billion by 2030, registering a CAGR of 10.2% from 2025 to 2030, according to a new report by Grand View Research, Inc. The demand for bioanalytical testing services has significantly increased over the past few years, thereby positively impacting the growth of the market.

This is primarily due to the growing R&D activities in the biopharmaceutical industry, leading to notable investments in the space. Also, the ongoing pandemic of COVID-19 has resulted in the expansion of manufacturing and R&D capabilities of key stakeholders leading to increased demand for bioanalytical testing services. The use of advanced technologies in vaccine and cell gene therapy development has led to significant growth of this space.

Advancements in instrumentation have created lucrative opportunities for contract manufacturers. Over the past several years, biopharmaceutical manufacturers are outsourcing at least some part of their biomanufacturing activities. Analytical testing is one of the most outsourced activities as it requires highly specialized personnel and equipment to conduct assays. These factors are anticipated to play a vital role in shaping market growth.

Large Molecule Bioanalytical Technologies Market Report Highlights:

• In 2024, the product segment dominated the market with the largest revenue share of 71.5%, propelled by the growing demand for advanced tools and instruments used in the analysis of biologics.
• Based on application, the biologics segment secured the largest revenue share in 2024, due to the rapid growth of biologics, including monoclonal antibodies, gene therapies, and biosimilars.
• The cell and gene therapy application segment is expected to grow at the fastest CAGR during the forecast period.
• In 2024, North America held the largest revenue share of 34.2% in the global market, driven by the rising trend of regenerative medicine and the growing focus on cancer and rare diseases.
• Asia Pacific is anticipated to be the fastest-growing region with a CAGR of 11.7% over the forecast

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Products & Services
  • 1.2.2. Application
  • 1.2.3. Regional Scope
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Large Molecule Bioanalytical Technologies Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrant
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. Large Molecule Bioanalytical Technologies Market: Products & Services Business Analysis

• 4.1. Products & Services Market Share, 2024 & 2030
• 4.2. Products & Services Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, By Products & Services, 2018 to 2030 (USD Million)
• 4.4. Products
  • 4.4.1. Products Market, 2018 - 2030 (USD Million)
  • 4.4.2. Consumables & Accessories
    • 4.4.2.1. Consumables & Accessories Market, 2018 - 2030 (USD Million)
  • 4.4.3. Instruments
    • 4.4.3.1. Instruments Market, 2018 - 2030 (USD Million)
  • 4.4.4. Reagents & Kits
    • 4.4.4.1. Reagents & Kits Market, 2018 - 2030 (USD Million)
• 4.5. Services
  • 4.5.1. Services Market, 2018 - 2030 (USD Million)

Chapter 5. Large Molecule Bioanalytical Technologies Market: Application Business Analysis

• 5.1. Application Market Share, 2024 & 2030
• 5.2. Application Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, By Application, 2018 to 2030 (USD Million)
• 5.4. Biologics
  • 5.4.1. Biologics Market, 2018 - 2030 (USD Million)
• 5.5. Oligonucleotide Derived Drugs & Molecules
  • 5.5.1. Oligonucleotide Derived Drugs & Molecules Market, 2018 - 2030 (USD Million)
• 5.6. Viral Vector
  • 5.6.1. Viral Vector Market, 2018 - 2030 (USD Million)
• 5.7. Cell & Gene Therapy
  • 5.7.1. Cell & Gene Therapy Market, 2018 - 2030 (USD Million)
• 5.8. Nanoparticles & Polymers
  • 5.8.1. Nanoparticles & Polymers Market, 2018 - 2030 (USD Million)

Chapter 6. Large Molecule Bioanalytical Technologies Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Share Analysis, 2024 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 6.4. North America
  • 6.4.1. North America Large Molecule Bioanalytical Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.2. U.S.
    • 6.4.2.1. Key Country Dynamic
    • 6.4.2.2. Regulatory Framework
    • 6.4.2.3. Competitive Insights
    • 6.4.2.4. U.S. Large Molecule Bioanalytical Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.3. Canada
    • 6.4.3.1. Key Country Dynamic
    • 6.4.3.2. Regulatory Framework
    • 6.4.3.3. Competitive Insights
    • 6.4.3.4. Canada Large Molecule Bioanalytical Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.4. Mexico
    • 6.4.4.1. Key Country Dynamic
    • 6.4.4.2. Regulatory Framework
    • 6.4.4.3. Competitive Insights
    • 6.4.4.4. Mexico Large Molecule Bioanalytical Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Europe
  • 6.5.1. Europe Large Molecule Bioanalytical Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. UK
    • 6.5.2.1. Key Country Dynamic
    • 6.5.2.2. Regulatory Framework
    • 6.5.2.3. Competitive Insights
    • 6.5.2.4. UK Large Molecule Bioanalytical Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Germany
    • 6.5.3.1. Key Country Dynamic
    • 6.5.3.2. Regulatory Framework
    • 6.5.3.3. Competitive Insights
    • 6.5.3.4. Germany Large Molecule Bioanalytical Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.4. France
    • 6.5.4.1. Key Country Dynamic
    • 6.5.4.2. Regulatory Framework
    • 6.5.4.3. Competitive Insights
    • 6.5.4.4. France Large Molecule Bioanalytical Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.5. Italy
    • 6.5.5.1. Key Country Dynamic
    • 6.5.5.2. Regulatory Framework
    • 6.5.5.3. Competitive Insights
    • 6.5.5.4. Italy Large Molecule Bioanalytical Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.6. Spain
    • 6.5.6.1. Key Country Dynamic
    • 6.5.6.2. Regulatory Framework
    • 6.5.6.3. Competitive Insights
    • 6.5.6.4. Spain Large Molecule Bioanalytical Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.7. Denmark
    • 6.5.7.1. Key Country Dynamic
    • 6.5.7.2. Regulatory Framework
    • 6.5.7.3. Competitive Insights
    • 6.5.7.4. Denmark Large Molecule Bioanalytical Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.8. Sweden
    • 6.5.8.1. Key Country Dynamic
    • 6.5.8.2. Regulatory Framework
    • 6.5.8.3. Competitive Insights
    • 6.5.8.4. Sweden Large Molecule Bioanalytical Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.9. Norway
    • 6.5.9.1. Key Country Dynamic
    • 6.5.9.2. Regulatory Framework
    • 6.5.9.3. Competitive Insights
    • 6.5.9.4. Norway Large Molecule Bioanalytical Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Asia Pacific
  • 6.6.1. Asia Pacific Large Molecule Bioanalytical Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.2. Japan
    • 6.6.2.1. Key Country Dynamic
    • 6.6.2.2. Regulatory Framework
    • 6.6.2.3. Competitive Insights
    • 6.6.2.4. Japan Large Molecule Bioanalytical Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. China
    • 6.6.3.1. Key Country Dynamic
    • 6.6.3.2. Regulatory Framework
    • 6.6.3.3. Competitive Insights
    • 6.6.3.4. China Large Molecule Bioanalytical Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.4. India
    • 6.6.4.1. Key Country Dynamic
    • 6.6.4.2. Regulatory Framework
    • 6.6.4.3. Competitive Insights
    • 6.6.4.4. India Large Molecule Bioanalytical Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.5. Australia
    • 6.6.5.1. Key Country Dynamic
    • 6.6.5.2. Regulatory Framework
    • 6.6.5.3. Competitive Insights
    • 6.6.5.4. Australia Large Molecule Bioanalytical Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.6. Thailand
    • 6.6.6.1. Key Country Dynamic
    • 6.6.6.2. Regulatory Framework
    • 6.6.6.3. Competitive Insights
    • 6.6.6.4. Thailand Large Molecule Bioanalytical Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.7. South Korea
    • 6.6.7.1. Key Country Dynamic
    • 6.6.7.2. Regulatory Framework
    • 6.6.7.3. Competitive Insights
    • 6.6.7.4. South Korea Large Molecule Bioanalytical Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Latin America
  • 6.7.1. Latin America Large Molecule Bioanalytical Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.2. Brazil
    • 6.7.2.1. Key Country Dynamic
    • 6.7.2.2. Regulatory Framework
    • 6.7.2.3. Competitive Insights
    • 6.7.2.4. Brazil Large Molecule Bioanalytical Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.3. Argentina
    • 6.7.3.1. Key Country Dynamic
    • 6.7.3.2. Regulatory Framework
    • 6.7.3.3. Competitive Insights
    • 6.7.3.4. Argentina Large Molecule Bioanalytical Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. Middle East and Africa
  • 6.8.1. Middle East and Africa Large Molecule Bioanalytical Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.2. South Africa
    • 6.8.2.1. Key Country Dynamic
    • 6.8.2.2. Regulatory Framework
    • 6.8.2.3. Competitive Insights
    • 6.8.2.4. South Africa Large Molecule Bioanalytical Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.3. Saudi Arabia
    • 6.8.3.1. Key Country Dynamic
    • 6.8.3.2. Regulatory Framework
    • 6.8.3.3. Competitive Insights
    • 6.8.3.4. Saudi Arabia Large Molecule Bioanalytical Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.4. UAE
    • 6.8.4.1. Key Country Dynamic
    • 6.8.4.2. Regulatory Framework
    • 6.8.4.3. Competitive Insights
    • 6.8.4.4. UAE Large Molecule Bioanalytical Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.5. Kuwait
    • 6.8.5.1. Key Country Dynamic
    • 6.8.5.2. Regulatory Framework
    • 6.8.5.3. Competitive Insights
    • 6.8.5.4. Kuwait Large Molecule Bioanalytical Technologies Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Participant Overview
• 7.2. Company Market Position Analysis
• 7.3. Company Categorization
• 7.4. Strategy Mapping
• 7.5. Company Profiles/Listing
  • 7.5.1. Intertek Group plc
    • 7.5.1.1. Participant's Overview
    • 7.5.1.2. Financial Performance
    • 7.5.1.3. Product Benchmarking
    • 7.5.1.4. Strategic Initiatives
  • 7.5.2. Solvias
    • 7.5.2.1. Participant's Overview
    • 7.5.2.2. Financial Performance
    • 7.5.2.3. Product Benchmarking
    • 7.5.2.4. Strategic Initiatives
  • 7.5.3. Bio-Techne
    • 7.5.3.1. Participant's Overview
    • 7.5.3.2. Financial Performance
    • 7.5.3.3. Product Benchmarking
    • 7.5.3.4. Strategic Initiatives
  • 7.5.4. Waters Corporation
    • 7.5.4.1. Participant's overview
    • 7.5.4.2. Financial Performance
    • 7.5.4.3. Product Benchmarking
    • 7.5.4.4. Strategic Initiatives
  • 7.5.5. Cytiva
    • 7.5.5.1. Participant's Overview
    • 7.5.5.2. Financial Performance
    • 7.5.5.3. Product Benchmarking
    • 7.5.5.4. Strategic Initiatives
  • 7.5.6. Verder Scientific GmbH & Co. KG
    • 7.5.6.1. Participant's Overview
    • 7.5.6.2. Financial Performance
    • 7.5.6.3. Product Benchmarking
    • 7.5.6.4. Strategic Initiatives
  • 7.5.7. Halo Labs
    • 7.5.7.1. Participant's Overview
    • 7.5.7.2. Financial Performance
    • 7.5.7.3. Product Benchmarking
    • 7.5.7.4. Strategic Initiatives
  • 7.5.8. Charles River Laboratories
    • 7.5.8.1. Participant's Overview
    • 7.5.8.2. Financial Performance
    • 7.5.8.3. Product Benchmarking
    • 7.5.8.4. Strategic Initiatives
  • 7.5.9. Avomeen
    • 7.5.9.1. Participant's Overview
    • 7.5.9.2. Financial Performance
    • 7.5.9.3. Product Benchmarking
    • 7.5.9.4. Strategic Initiatives
  • 7.5.10. Merck KGaA
    • 7.5.10.1. Participant's Overview
    • 7.5.10.2. Financial Performance
    • 7.5.10.3. Product Benchmarking
    • 7.5.10.4. Strategic Initiatives
  • 7.5.11. Cergentis B.V.
    • 7.5.11.1. Participant's Overview
    • 7.5.11.2. Financial Performance
    • 7.5.11.3. Product Benchmarking
    • 7.5.11.4. Strategic Initiatives
  • 7.5.12. Labcorp
    • 7.5.12.1. Participant's Overview
    • 7.5.12.2. Financial Performance
    • 7.5.12.3. Product Benchmarking
    • 7.5.12.4. Strategic Initiatives
  • 7.5.13. SCIEX
    • 7.5.13.1. Participant's Overview
    • 7.5.13.2. Financial Performance
    • 7.5.13.3. Product Benchmarking
    • 7.5.13.4. Strategic Initiatives
  • 7.5.14. F. Hoffmann-La Roche Ltd
    • 7.5.14.1. Participant's Overview
    • 7.5.14.2. Financial Performance
    • 7.5.14.3. Product Benchmarking
    • 7.5.14.4. Strategic Initiatives
  • 7.5.15. Bio-Rad Laboratories, Inc.
    • 7.5.15.1. Participant's Overview
    • 7.5.15.2. Financial Performance
    • 7.5.15.3. Product Benchmarking
    • 7.5.15.4. Strategic Initiatives

관련자료